BACKGROUND AND PURPOSE: Children with medulloblastoma demonstrate post-treatment neurocognitive deficits in a number of areas, including memory performance. However, there is no definitive understanding of the neuropathology underlying these functional deficits. Previous literature has reported that hippocampal integrity is crucial to the acquisition of new episodic memories. Therefore, we hypothesized that longitudinal hippocampal volume measurements are abnormal in patients with medulloblastoma and thereby provide a possible substrate for explaining memory dysfunction. METHODS: Twenty-five pediatric patients underwent 159 serial MR imaging examinations (mean = six examinations per patient) for up to 5 years after irradiation and chemotherapy treatment for medulloblastoma. Right and left hippocampal volumes were obtained by manually tracing 1.5-mm contiguous coronal sections through the structure. Random coefficient models were used to examine longitudinal change in hippocampal volume as a function of time after diagnosis. RESULTS: Both right and left hippocampal volumes initially decreased after treatment. This abnormal volume pattern continued until approximately 2-3 years after diagnosis, when hippocampal volumes returned toward a normal positive growth pattern. Volume loss occurred predominately in the posterior regions. Female sex, low parental education, shunt placement, and positive seizure history all had a significant negative impact on hippocampal volume. CONCLUSION: Pediatric medulloblastoma survivors demonstrate an abnormal pattern of hippocampal volume development after treatment. Radiation dose mapping may expand our understanding of region-specific changes in hippocampal volume. Further exploration of the relationships between radiation therapy, memory dysfunction, and hippocampal pathology in this population is warranted. Copyright American Society of Neuroradiology
BACKGROUND AND PURPOSE:Children with medulloblastoma demonstrate post-treatment neurocognitive deficits in a number of areas, including memory performance. However, there is no definitive understanding of the neuropathology underlying these functional deficits. Previous literature has reported that hippocampal integrity is crucial to the acquisition of new episodic memories. Therefore, we hypothesized that longitudinal hippocampal volume measurements are abnormal in patients with medulloblastoma and thereby provide a possible substrate for explaining memory dysfunction. METHODS: Twenty-five pediatric patients underwent 159 serial MR imaging examinations (mean = six examinations per patient) for up to 5 years after irradiation and chemotherapy treatment for medulloblastoma. Right and left hippocampal volumes were obtained by manually tracing 1.5-mm contiguous coronal sections through the structure. Random coefficient models were used to examine longitudinal change in hippocampal volume as a function of time after diagnosis. RESULTS: Both right and left hippocampal volumes initially decreased after treatment. This abnormal volume pattern continued until approximately 2-3 years after diagnosis, when hippocampal volumes returned toward a normal positive growth pattern. Volume loss occurred predominately in the posterior regions. Female sex, low parental education, shunt placement, and positive seizure history all had a significant negative impact on hippocampal volume. CONCLUSION: Pediatric medulloblastoma survivors demonstrate an abnormal pattern of hippocampal volume development after treatment. Radiation dose mapping may expand our understanding of region-specific changes in hippocampal volume. Further exploration of the relationships between radiation therapy, memory dysfunction, and hippocampal pathology in this population is warranted. Copyright American Society of Neuroradiology
Authors: R K Mulhern; S L Palmer; W E Reddick; J O Glass; L E Kun; J Taylor; J Langston; A Gajjar Journal: J Clin Oncol Date: 2001-01-15 Impact factor: 44.544
Authors: H Hodges; N Katzung; P Sowinski; J W Hopewell; J H Wilkinson; T Bywaters; M Rezvani Journal: Behav Brain Res Date: 1998-03 Impact factor: 3.332
Authors: R K Mulhern; W E Reddick; S L Palmer; J O Glass; T D Elkin; L E Kun; J Taylor; J Langston; A Gajjar Journal: Ann Neurol Date: 1999-12 Impact factor: 10.422
Authors: J Grill; V K Renaux; C Bulteau; D Viguier; C Levy-Piebois; C Sainte-Rose; G Dellatolas; M A Raquin; I Jambaqué; C Kalifa Journal: Int J Radiat Oncol Biol Phys Date: 1999-08-01 Impact factor: 7.038
Authors: Wilburn E Reddick; Holly A White; John O Glass; Gregory C Wheeler; Stephen J Thompson; Amar Gajjar; Laurie Leigh; Raymond K Mulhern Journal: Cancer Date: 2003-05-15 Impact factor: 6.860
Authors: Regula S Briellmann; Samuel F Berkovic; Ari Syngeniotis; Mark A King; Graeme D Jackson Journal: Ann Neurol Date: 2002-05 Impact factor: 10.422
Authors: S Duke Han; Wes S Houston; Amy J Jak; Lisa T Eyler; Bonnie J Nagel; Adam S Fleisher; Gregory G Brown; Jody Corey-Bloom; David P Salmon; Leon J Thal; Mark W Bondi Journal: Neurobiol Aging Date: 2006-01-24 Impact factor: 4.673
Authors: Malin Blomstrand; N Patrik Brodin; Per Munck Af Rosenschöld; Ivan R Vogelius; Gaspar Sánchez Merino; Anne Kiil-Berthlesen; Klas Blomgren; Birgitta Lannering; Søren M Bentzen; Thomas Björk-Eriksson Journal: Neuro Oncol Date: 2012-05-17 Impact factor: 12.300
Authors: Kimberly P Raghubar; Michael Lamba; Kim M Cecil; Keith Owen Yeates; E Mark Mahone; Christina Limke; David Grosshans; Travis J Beckwith; M Douglas Ris Journal: Pediatr Blood Cancer Date: 2018-06-01 Impact factor: 3.167
Authors: Carol L Armstrong; David M Shera; Robert A Lustig; Peter C Phillips Journal: Int J Radiat Oncol Biol Phys Date: 2012-03-13 Impact factor: 7.038
Authors: A Horská; A Laclair; M Mohamed; C T Wells; T McNutt; K J Cohen; M Wharam; E M Mahone; W Kates Journal: AJNR Am J Neuroradiol Date: 2010-05-06 Impact factor: 3.825
Authors: Katherine J Bangen; Khaled Restom; Thomas T Liu; Amy J Jak; Christina E Wierenga; David P Salmon; Mark W Bondi Journal: Neurobiol Aging Date: 2007-12-21 Impact factor: 4.673